VivoSeq
Other

Placebo Effect

0

Pipeline Programs↗

1

Active Trials↗

0

Companies Involved↗

Placebo Effect is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

7

clinical trials

Completed6 · 86%
Not yet recruiting1 · 14%

Clinical Trials

Trial Activity

7 trials

The Role of the Opioid System in Placebo Effects on Pain and Social Rejection
Not yet recruiting·TTrustees of Dartmouth College·Phase 1·NCT04650841·60 enrolled
Placebo Effects in the Treatment of Depression: Cognitive and Neural Mechanisms
Completed·NNew York State Psychiatric Institute·Phase 4·NCT01919216·65 enrolled
Placebo Effect of Paracetamol in Healthy Volunteers
Completed·UUniversity Hospital, Clermont-Ferrand·Phase 1·NCT01053650·40 enrolled
Interaction Between Drug and Placebo Effect:Randomized Placebo Controlled Trials May Not be Accurate in Determining Drug Effect Size
Completed·KKing Faisal Specialist Hospital & Research Center·N/A·NCT01501591·480 enrolled
Measuring Placebo Effect by Elimination and Investigating Mechanism of Action
Completed·KKing Faisal Specialist Hospital & Research Center·N/A·NCT00426010·180 enrolled
The Placebo Effect May Involve Modulating Drug Bioavailability
Completed·KKing Faisal Specialist Hospital & Research Center·N/A·NCT01501747·162 enrolled
Can Oxytocin Enhance the Placebo Effect?
Completed·UUniversity of Electronic Science and Technology of China·Phase 1·NCT02745522·224 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)